SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-017919
Filing Date
2023-05-04
Accepted
2023-05-04 16:25:45
Documents
13
Period of Report
2023-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20230504.htm   iXBRL 8-K 60004
2 EX-99.1 crnx-ex99_1.htm EX-99 135473
  Complete submission text file 0000950170-23-017919.txt   319849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20230504.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20230504_pre.xml EX-101.PRE 9455
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20230504_lab.xml EX-101.LAB 12806
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20230504_htm.xml XML 4549
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 23889178
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences